Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
Finance, Software

Bitcoin News: Projecting Next Price Rise For Bitcoins

The past weekend rounded up the recent trend of brutally high-volume selling on Chinese bitcoin exchanges. On 28th September, bitcoin dropped to a new five-month low of $372.35. The previous record low for Coindesk’s Bitcoin Price Index (BPI), is the six-month bottom reached on 10th April at $360.84. Meanwhile, trading volumes touched historical highs for the third consecutive week, with 73.8% of bitcoins traded over … Continue reading Bitcoin News: Projecting Next Price Rise For Bitcoins

Richard Atkins
BioTech, Finance

Halozyme Therapeutics, Inc (HALO) announced that the FDA has lifted the clinical hold from a phase Ib/II study (Study S1313). The study is evaluating PEGPH20 (PEGylated recombinant human hyaluronidase) in combination with a modified FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients suffering from metastatic pancreatic adenocarcinoma. The Study S1313, which is being sponsored and conducted by SWOG (a cancer research cooperative group funded primarily by the National … Continue reading

Richard Atkins
Finance, Internet

Stock in News: Microsoft (NASDAQ MSFT) To Open Major Store in Manhattan

After five years of planning, Microsoft to open shop, literally, at 677 Fifth Avenue. While Microsoft Corporation (NASDAQ MSFT) has been working its way into retail to push the Xbox and mobile products for years, the company is now ready to go big. “As our first flagship store, it will serve as the centerpiece of our Microsoft Stores experience,” said David Porter, corporate vice president … Continue reading Stock in News: Microsoft (NASDAQ MSFT) To Open Major Store in Manhattan

Richard Atkins
Finance, Internet

Stock Review: A Look At Google (NASDAQ GOOG) Nexus 6

Google Inc (NASDAQ GOOG)’s forthcoming Nexus 6 smartphone has been subject of a lot of rumours in the past few weeks. Some leaks claim that the search engine giant will drop the name Nexus 6 in favor of Nexus X. Others indicate that Google will unveil the Nexus 6 quietly rather than holding a mega-event to announce the device. Google’s next phone is rumored to … Continue reading Stock Review: A Look At Google (NASDAQ GOOG) Nexus 6

Richard Atkins
Finance, Internet

Active Stock: Facebook (NASDAQ FB) Look At Atlas For Marketing Revolution

Facebook Inc (NASDAQ FB) has enhanced Atlas ad server that will be launched fully this week, and has been dubbed as “marketing nirvana” by one of the digital advertising CEO, according to Ad Week. The social networking site is now opening its knowledge base of its billion users for all marketers, which according to experts is extraordinary and increases their capacity to target messages in … Continue reading Active Stock: Facebook (NASDAQ FB) Look At Atlas For Marketing Revolution

Richard Atkins
BioTech, Finance

Major Biotech Stock in News: Amgen Files Blinatumomab Marketing Application

Amgen (AMGN) announced that it has submitted a Biologics License Application (BLA) to the FDA for its oncology candidate, blinatumomab. The company is looking to get the candidate approved for the treatment of adults suffering from Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL). The BLA includes positive data from a phase II study which evaluated the use of blinatumomab in adults with Ph- relapsed/refractory … Continue reading Major Biotech Stock in News: Amgen Files Blinatumomab Marketing Application

Richard Atkins